PLGO

Pelagos Insurance CapitalA

NYSE / Insurance

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

Probability

Target price

$24.50

+16.0% vs current

Most likely

Base case

Probability

Target price

$21.50

+1.8% vs current

B-

Bear case

Probability

Target price

$17.50

-17.1% vs current

AI sentiment snapshot

Latest data as of 2026-05-13

AI commentary

Primary-source support improved materially after checking company IR pages, the 2025 Form 20-F, and company press releases, but the memo still sits in monitoring mode because current flow is dominated by rebrand/ticker-change and capital-return headlines rather than fresh operating results. Headline tone is mildly constructive, yet the key unresolved item is the Q1 2026 release due on May 13, 2026 after market close. No usable social-coverage packet or verified analyst-revision readout was available, so confidence stays below average despite the discount-to-book setup.

RankAlpha Sentiment Codex - 2026-05-13

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-13eventQ1 2026 results are due after market close on May 13, with call on May 14High impact

Management said first-quarter 2026 results would be released on May 13, 2026 after the close, with an investor call on May 14 at 9:00 a.m. ET, making the next 24 hours the main near-term evidence reset for underwriting, capital return execution, and book-value progression [#PR-2026-04-09].

2026-12-31catalystAccretive capital return program could support per-share value if underwriting holdsHigh impact

The board lifted total repurchase authorization to $400 million and declared a $0.15 dividend, while the company separately agreed to repurchase CVC's remaining 8.6 million shares at $19.00, which management said was below year-end diluted book value per share of $24.61 and expected to be accretive to book value per share and ROAE [#PR-2026-02-20] [#PR-2026-03-02].

2026-12-31catalystRetro protection and diversified specialty mix can reduce downside if loss activity stays containedMedium impact

The January Herbie Re issuance added $75 million of annual aggregate collateralized retrocessional protection through end-2029, while company materials show a diversified book with 2025 gross premiums written of $4.7 billion and an 82.1% combined ratio, which supports the monitoring case that earnings volatility may be better managed than in a less protected specialty writer [#PR-2026-01-22] [#20F-2025].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-05-13 • Updated nightlySource: Internal modelMethodology